Find similar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL 17780/1126.
Frovatriptan 2.5mg film coated tablets
Frovatriptan 2.5 mg Film-coated Tablets
1. What Frovatriptan 2.5 mg Film-coated Tablets is and what it is used for
2. What you need to know before you take Frovatriptan 2.5 mg Film-coated Tablets
3. How to take Frovatriptan 2.5 mg Film-coated Tablets
4. Possible side effects
5. How to store Frovatriptan 2.5 mg Film-coated Tablets
6. Contents of the pack and other information
Frovatriptan 2.5 mg Film-coated Tablets contain frovatriptan, an anti-migraine treatment belonging to the class of triptans (5-hydroxytryptamine (5-HT1) selective receptor agonists). It is a medicine for the treatment of the headache phase of a migraine attack with or without aura (a temporary strange feeling before a migraine attack, which varies from person to person but can affect, for example, vision, smell, hearing).
Frovatriptan 2.5 mg Film-coated Tablets should not be used to prevent migraine attacks. Frovatriptan 2.5 mg Film-coated Tablets is used to treat migraine attacks in adults.
The diagnosis of migraine must have been clearly established by your doctor.
Do not take Frovatriptan 2.5 mg Film-coated Tablets:
Talk to your doctor before taking this medicine if you are a patient at risk of coronary artery disease, including if:
Stop taking Frovatriptan 2.5 mg Film-coated Tablets and talk to your doctor right away if you:
Do not give this medicine to children and adolescents (under 18 years of age) because the safety and efficacy of this medicine has not been established in these groups.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
You should not take this medicine at the same time as certain other medicines used for the treatment of migraine:
It is recommended that you do not take Frovatriptan 2.5 mg Film-coated Tablets together with St John's Wort (Hypericum perforatum).
Concomitant use of Frovatriptan 2.5 mg Film-coated Tablets with the medicines listed above (especially monoamine oxidase inhibitors, selective serotonin-reuptake inhibitors and Hypericum perforatum) may also increase the risk of serotonin syndrome (the symptoms of this syndrome include: shivering, sweating, agitation, trembling and abrupt contraction of muscles, nausea, fever and confusion).
If you have any doubt about taking other medicines and Frovatriptan 2.5 mg Film-coated Tablets, consult your doctor or pharmacist.
This medicine can be taken with food or on an empty stomach, always with an adequate amount of water.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Frovatriptan 2.5 mg Film-coated Tablets should not be used during pregnancy or when breast feeding, unless you are told so by your doctor. In any case, you should not breast-feed for 24 hours after taking this medicine and during this time any breast milk expressed should be discarded.
Frovatriptan 2.5 mg Film-coated Tablets and the migraine itself can cause drowsiness.
If affected, driving or operating machinery can be dangerous and should be avoided.
This product contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially “sodium-free”.
Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure.
Take Frovatriptan 2.5 mg Film-coated Tablets as early as possible after the onset of the migraine headache. Swallow one tablet whole with water.
If the first dose does not give you any relief, do not take a second dose during the same attack. You can use Frovatriptan 2.5 mg Film-coated Tablets for any following attacks.
If you obtain relief after the first dose, but later on suffer from the re-appearance of a headache within 24 hours, you can take second dose provided that at least 2 hours have elapsed between the 2 doses.
Do not exceed the maximum dose of 5 mg (two tablets) in 24 hours.
Excessive use (repeated use over several consecutive days) of Frovatriptan 2.5 mg Film-coated Tablets constitutes incorrect use of this medicine and may cause an increase in side effects and lead to chronic daily headaches requiring the temporary discontinuation of treatment. Consult your doctor if you start having too frequent or daily headaches as you may be suffering from medication overuse headache.
Frovatriptan 2.5 mg Film-coated Tablets should not be used in patients under 18 years of age.
As there is little experience in patients over 65 years, the use of this medicine is not recommended in this age group.
If you accidentally take an overdose of this medicine, tell your doctor or pharmacist immediately, or go to the emergency department of your nearest hospital. Please remember to take the remaining tablets or this leaflet with you.
No special precautions are necessary when stopping the drug.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking this medicine and tell your doctor right away if you experience any of the following symptoms:
The side effects reported with Frovatriptan 2.5 mg Film-coated Tablets were temporary, generally mild to moderate and spontaneously disappeared. Some symptoms reported may be caused by the migraine itself.
The following side effects were commonly observed (may affect up to 1 in 10 people):
The following effects were uncommonly observed (may affect up to 1 in 100 people):
The following effects were rare (may affect up to 1 in 1,000 people):
Although the frequency cannot be estimated from the available data, the following events were also reported:
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via UK Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not store above 30°C.
Do not use this medicine after the expiry date which is stated on the blister and on the outer carton after EXP.
The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is frovatriptan.
Each film-coated tablet contains 2.5 mg of frovatriptan (as frovatriptan succinate monohydrate).
The other ingredients are:
Tablet core: silicified microcrystalline cellulose, lactose anhydrous*, silicon dioxide, sodium starch glycolate (Type A) and magnesium stearate.
Film-coating: hypromellose (E464), lactose monohydrate*, macrogol 3350 (E1521), triacetin and titanium dioxide (E171).
*Contains approximately 107 mg of lactose per tablet.
Frovatriptan 2.5 mg Film-coated Tablets are white to off white round film-coated tablets, plain on both sides. They are available in blister packs of 1, 2, 3, 4, 6 or 12 tablets.
Not all pack sizes may be marketed.
This leaflet was last revised in April 2025
1065045934